NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
09/16/2025
Back to search
Official data from USPTO
CYTOCHIP
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
02/14/2026
Trademark type
Word
Nice classes
10
Filing date
11/09/2016
Registration date
09/19/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
02/14/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/09/2016
First use in commerce
11/09/2016
Drawing code
4
Owner type
03
Owner location
Irvine, CA
Examiner
PARK, JENNY K
Current location
Historical data usage
Holders and representatives
Holders
CytoChip Inc.
CytoChip Inc.
Representatives
Anna M. Quinn AVEK IP, LLC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Cytometers for medical diagnostic use; Diagnostic apparatus for the detection of cancer; Diagnostic kits consisting primarily of probesbuffers and reagents for use in microbial testing; Hematology analyzers for medical diagnostic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometershematology analyzerssample preparation devicerelated data management software sold as a unit; Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; Medical apparatus and units for dosagemeasuring and monitoringdrug delivery devices and systems; Medical apparatus and instrument for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing; Medical device for detecting cancer; Medical device for treating cancer; Medical devicestubing and valve assembly set and electromechanical fluidic instrumentother similar or related deviceswhich process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; Medical diagnostic apparatus for detecting cancer; Medical diagnostic instruments for the analysis of body fluids; Sample preparation device for medical diagnostic uses; Flow cytometers and flow-based analyzers providing cell and particle analysisdetectioncounting for medicalclinicalmedical diagnostictherapeutic uses; Flow cytometers for medical diagnostic uses; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometershematology analyzerssample preparation devicerelated data management software sold as a unit; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometershematology analyzerssample preparation devicerelated data management software sold as a unit; Instrument and apparatus systems for medical diagnostic uses consisting of flow cytometershematology analyzerssample preparation devicerelated data management software sold as a unit
Publications
History of USPTO decisions and trademark events.
27 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/25/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/27/2025
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
04/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/07/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/07/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/04/2024
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/04/2024
E815
TEAS SECTION 8 & 15 RECEIVED
11/28/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
09/19/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/12/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/11/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/22/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/21/2017
IUAF
USE AMENDMENT FILED
06/22/2017
EISU
TEAS STATEMENT OF USE RECEIVED
06/22/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2017
PUBO
PUBLISHED FOR OPPOSITION
02/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/18/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/05/2017
DOCK
ASSIGNED TO EXAMINER
01/05/2017
MPMK
NOTICE OF PSEUDO MARK E-MAILED
11/16/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/15/2016
NWAP
NEW APPLICATION ENTERED
11/12/2016
Continuous trademark protection
Get notified about every new filing that threatens CYTOCHIP or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.